Clinical Trial Update: Prochlorperazine Versus Prochlorperazine & Ketorolac in Treatment of Pediatric Migraine in the Emergency Department [Phase 4]

View source ↗

Summary

A Phase 4 pediatric migraine trial comparing prochlorperazine alone versus prochlorperazine with ketorolac in the emergency department has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Compazine (Prochlorperazine)
• Toradol (ketorolac tromethamine)

Snippet

Sponsor: Akron Children's Hospital | Conditions: Migraine | Phase 4 | Status: WITHDRAWN